- Home
- OPK vs MDXG Comparison
OPK vs MDXG Comparison
Compare OPK & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- MDXG
- Stock Information
- Founded
- OPK 2007
- MDXG 2006
- Country
- OPK United States
- MDXG United States
- Employees
- OPK N/A
- MDXG N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- OPK Health Care
- MDXG Health Care
- Exchange
- OPK Nasdaq
- MDXG Nasdaq
- Market Cap
- OPK 1.0B
- MDXG 1.1B
- IPO Year
- OPK 1995
- MDXG N/A
- Fundamental
- Price
- OPK $1.39
- MDXG $6.92
- Analyst Decision
- OPK Buy
- MDXG Buy
- Analyst Count
- OPK 4
- MDXG 1
- Target Price
- OPK $2.75
- MDXG $12.00
- AVG Volume (30 Days)
- OPK 1.9M
- MDXG 430.1K
- Earning Date
- OPK 11-06-2025
- MDXG 10-29-2025
- Dividend Yield
- OPK N/A
- MDXG N/A
- EPS Growth
- OPK N/A
- MDXG N/A
- EPS
- OPK N/A
- MDXG 0.21
- Revenue
- OPK $664,029,000.00
- MDXG $363,774,000.00
- Revenue This Year
- OPK N/A
- MDXG $12.68
- Revenue Next Year
- OPK $0.84
- MDXG $8.18
- P/E Ratio
- OPK N/A
- MDXG $33.06
- Revenue Growth
- OPK N/A
- MDXG 6.85
- 52 Week Low
- OPK $1.11
- MDXG $5.47
- 52 Week High
- OPK $2.04
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- OPK 51.08
- MDXG 46.16
- Support Level
- OPK $1.34
- MDXG $6.81
- Resistance Level
- OPK $1.44
- MDXG $7.14
- Average True Range (ATR)
- OPK 0.04
- MDXG 0.18
- MACD
- OPK -0.00
- MDXG -0.04
- Stochastic Oscillator
- OPK 45.00
- MDXG 29.55
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.